PDLI Operating Cash Flow Growth
Pdl Biopharma Inc · Operating Cash Flow Growth
PDLI Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported185.73%period ending
PDLI TTM Cash from Operations YoY % (35.87% → 185.73%)
Year-over-year change
High-resolution chart · PNG
PDLI operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 185.7338% | |
| -2,955.9111% | |
| -1,313.9883% | |
| -141.6611% | |
| 46.6456% | |
| 95.4742% | |
| 124.6855% | |
| -133.047% | |
| -139.0661% | |
| -159.4126% | |
| -133.9655% | |
| -60.0621% | |
| -52.7897% | |
| -71.4635% | |
| -82.9277% | |
| -66.2588% | |
| -48.0261% | |
| -20.4322% | |
| 18.277% | |
| 3.1422% | |
| 5.6175% | |
| 19.2895% | |
| -11.767% | |
| 7.8966% | |
| 8.87% | |
| 0.7609% | |
| 25.3122% | |
| 28.8627% | |
| 28.2213% | |
| 22.7826% | |
| 22.651% | |
| 23.8152% | |
| 31.7838% | |
| 37.7238% | |
| 39.2603% | |
| -7.8774% | |
| -25.8271% | |
| -28.2866% | |
| -22.5404% | |
| -1.4196% | |
| 72.1313% | |
| 17.7265% | |
| 35.7044% | |
| 133.2581% | |
| 3.4263% | |
| 515.5632% | |
| 193.4108% | |
| 19.6736% | |
| 162.3801% | |
| -64.9273% | |
| -30.6066% | |
| -14.9765% | |
| -42.9295% | |
| 5.7215% | |
| 58.835% | |
| 149.6672% | |
| 474.9007% | |
| 648.1058% | |
| 243.0952% | |
| 216.1806% | |
| 150.1882% | |
| 71.1038% | |
| 16.9044% | |
| -18.2495% | |
| -114.7033% | |
| -6,444.086% | |
| -5,522.0365% | |
| -352.8693% | |
| -2,030.1223% | |
| -114.283% | |
| -85.9911% | |
| -295.9428% | |
| -92.8719% | |
| 243.8553% | |
| 53.1464% | |
| -62.0917% | |
| 205.8857% | |
| -183.975% | |
| 146.6464% | |
| 162.0636% | |
| -147.5714% | |
| 234.75% | |
| 0.3788% | |
| -69.2308% | |
| 36.3636% | |
| 45.7627% | |
| -24.5283% | |
| 14.4737% | |
| 27.6316% | |
| 35.8696% |